Kadir Caliskan

Kadir Caliskan is a Ph.D. Researcher in the Department of Cardiology at Erasmus MC, Rotterdam, The Netherlands, holding the prestigious Fellow of the European Society of Cardiology (FESC) designation. With over 250 publications and an active ORCID profile (0000-0002-3293-9261), his research significantly impacts cardiac mechanical support and heart failure management.

His primary research domains include Left Ventricular Assist Devices (100% fingerprint prominence), congestive heart failure (53%), heart transplantation (37%), and noncompaction cardiomyopathy (34%). His methodology frequently employs registry analyses and systematic reviews to investigate adverse events, arrhythmias, and vascular complications in complex cardiac patients, bridging clinical practice with evidence-based innovation.

Recent 2025 publications reveal a strategic focus on LVAD risk-benefit trade-offs, genetic cardiomyopathy mechanisms (particularly RBM20-associated conditions), and advanced imaging biomarkers like myocardial thinning and aortic elasticity. These works demonstrate his leadership in multicenter collaborations such as the EUROMACS registry, addressing critical gaps in mechanical circulatory support outcomes.

His recognized achievement includes:

• Fellow of the European Society of Cardiology (FESC)

Dr. Caliskan has supervised 7 research projects, mentoring emerging scientists in cardiac research. His extensive publication record in high-impact journals indicates substantial research funding support, though specific grant details aren't disclosed in available materials. His work consistently targets improved therapeutic strategies for refractory heart failure cases through rigorous clinical investigation.